Transfection Life Science Dashboard Series 2

Table of Contents

• 6. Figures and Tables
• 10. Executive Summary
• 12. Key Findings and Implications
• 15. Transfection Dashboard
• 19. Transfection Market Opportunity Matrix
• 21. Survey Methodology
• 22. Survey Invitation Text
• 24. Respondent Demographics
• 37. Frequency of Performance of Life Science Techniques
• 42. Frequency of Transfection of Mammalian Cells or Cell Lines
• 54. Reaction Throughput and Market Growth Rates
• 60. Respondent' s Stated Price Per Reaction
• 63. Total Market Size, Market Segment Sizes and Total Market Growth Rate
• 66. Market Shares for Products for Chemically-Mediated Transfection of Mammalian Cells or Cell Lines
• 70. Market Shares for Products for Lipid-Mediated Transfection of Mammalian Cells or Cell Lines
• 74. Market Shares for Products for Instrument-Mediated Transfection of Mammalian Cells or Cell Lines
• 78. Market Shares for Products for Virus-Mediated Transfection of Mammalian Cells or Cell Lines
• 83. Customer Satisfaction And Interest In Switching Suppliers
• 90. Product Features That Influence Purchasing Decisions
• 94. Primary and Secondary Downstream Applications
• 114. Desired Changes to Transfection Products
• 122. Survey Questionnaire 26

FIGURES:

• Figure 1: Respondent' s Place of Employment
• Figure 2: Respondent' s Country/Region
• Figure 3: Respondent' s Job Title
• Figure 4: Respondent' s Areas of Expertise/Specialization
• Figure 5: Number of Employees in Respondent' s Laboratories
• Figure 6: Percentage of Respondents Performing Various Life Science Techniques at Least a Few Times per Year
• Figure 7: Percentage of Respondents Transfecting Mammalian Cells or Cell Lines
• Figure 8: Percentage of Respondents Performing Transfection of Mammalian Cells or Cell Lines at Least a Few Times Per Year
• Figure 9: Percentage of Respondents Performing Chemically-Mediated Transfection of Mammalian Cells or Cell Lines
• Figure 10: Percentage of Respondents Performing Lipid-Mediated Transfection of Mammalian Cells or Cell Lines
• Figure 11: Percentage of Respondents Performing Instrument-Mediated Transfection of Mammalian Cells or Cell Lines
• Figure 12: Percentage of Respondents Performing Virus-Mediated Transfection of Mammalian Cells or Cell Lines
• Figure 13: Respondent' s Primary Supplier for Chemically-Mediated Transfection of Mammalian Cells or Cell Lines
• Figure 14: Respondent' s Primary Supplier for Lipid-Mediated Transfection of Mammalian Cells or Cell Lines
• Figure 15: Respondent' s Primary Supplier for Instrument-Mediated Transfection of Mammalian Cells or Cell Lines
• Figure 16: Respondent' s Primary Supplier for Virus-Mediated Transfection of Mammalian Cells or Cell Lines
• Figure 17: Percentage of Respondents That Have Switched Suppliers in the Last Six Months
• Figure 18: Percentage of Respondents That Have Switched from the following Suppliers to a Different Supplier in the Last Six Months
• Figure 19: Most Important Features of Transfection Products
• Figure 20: Respondent' s Primary Application for Mammalian Cells or Cell Lines After Chemically-Mediated Transfection
• Figure 21: Respondent' s Primary and Secondary Applications for Mammalian Cells or Cell Lines After Chemically-Mediated Transfection
• Figure 22: Respondent' s Primary Application for Mammalian Cells or Cell Lines After Lipid-Mediated Transfection
• Figure 23: Respondent' s Primary and Secondary Applications for Mammalian Cells or Cell Lines After Lipid-Mediated Transfection
• Figure 24: Respondent' s Primary Applications for Mammalian Cells or Cell Lines After Instrument-Mediated Transfection
• Figure 25: Respondent' s Primary and Secondary Applications for Mammalian Cells or Cell Lines After Instrument-Mediated Transfection
• Figure 26: Respondent' s Primary Applications for Mammalian Cells or Cell Lines After Virus-Mediated Transfection
• Figure 27: Respondent' s Primary and Secondary Applications for Mammalian Cells or Cell Lines After Instrument-Mediated Transfection